Methoxetamine: From drug of abuse to rapid-acting antidepressant-Reference-Cited by-同舟云学术

Methoxetamine: From drug of abuse to rapid-acting antidepressant

Published:2012-10 Issue:4 Volume:79 Page:504-507
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Coppola M.,Mondola R.

Publisher

Elsevier BV

Subject

General Medicine

Reference63 articles.

1. Bipolar disorder: from genes to behavior pathways;Martinowich;J Clin Invest,2009

2. Prevalence and predictors of recurrence of major depressive disorder in the adult population;Hardeveld;Acta Psychiatr Scand,2010

3. Major depressive disorder: new clinical, neurobiological, and treatment perspective;Kupfer;Lancet,2012

4. The epidemiology of major depressive disorder: results from the National Co morbidity Survey Replication (NCS-R);Kessels;J Am Med Assoc,2003

5. Lifetime prevalence and age-of-ones distributions of mental disorders in the World Health Organization’s World Mental Health Survey Initiative;Kessler;World Psychiatry,2007

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arylcyclohexamines;Novel Psychoactive Substances;2022

2. R (−)-methoxetamine exerts rapid and sustained antidepressant effects and fewer behavioral side effects relative to S (+)-methoxetamine;Neuropharmacology;2021-08

3. Hallucinogens and Psychedelics;Principles of Forensic Toxicology;2020

4. The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT2 receptors;Psychopharmacology;2019-03-19

5. Methoxetamine: A foe or friend?;Neurochemistry International;2019-01